Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Nov 1, 2017 · 10-Q · 32 days after period end · 0001069530-17-000036
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$2.59M | -$3.52M | -$3.67M | -$3.53M |
| EPS Diluted | -$0.40 | -$0.54 | -$0.08 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 1, 2017 · 32 d after period end
